Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2008
10/29/2008CN101294159A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection
10/29/2008CN101293930A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection
10/29/2008CN100429312C Overexpression, purification and characterization of a thermolabile phosphatase
10/29/2008CN100429232C Vaughan Tristan J.
10/29/2008CN100429230C Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
10/28/2008US7442784 For regulation of gene expression
10/28/2008US7442783 Natural IgM antibodies and inhibitors thereof
10/28/2008US7442769 Antifreeze proteins from basidiomy cetes
10/28/2008US7442768 amino acid sequences that can be used as in vivo fluorescent markers which can be expressed in host cells in in vitro cultures using mammal cells
10/28/2008US7442767 α1D calcium channel expressed in atrium
10/28/2008US7442550 Detection is established by the fusogenic power of the polypeptide, which is demonstrated by syncytia formation; use in drug testing or drug screening; HERV-W envelope glycoprotein; cancer gene therapy
10/28/2008US7442536 proteins is "cysteinized" to permit easier conjugation to a targeting moiety
10/28/2008US7442535 Fusion protein incorporating a cysteinized ribonuclease
10/28/2008US7442534 Nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteins
10/28/2008US7442527 Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
10/28/2008US7442526 co-expressing bicistronically caspase 4 with the human precursor IL-18 polypeptide and purifying the active polypeptide
10/28/2008US7442524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
10/28/2008US7442522 Nucleic acids encoding chromo or fluorescent proteins and method for using the same
10/28/2008US7442521 To generate transgenic, non-human plants or animals or site specific gene modifications in cell lines; fluorescent proteins high through-put screening assays; use as biosensors in prokaryotic and eukaryotic cells, fluorescence activated cell sorting applications, as markers following injection into cells
10/28/2008US7442520 modulator of tumor growth and metastasis in certain cancer types, especially breast and lung cancer
10/28/2008US7442519 KCNQ2-15 potassium channel
10/28/2008US7442516 Antibody specific to central nervous system tau protein
10/28/2008US7442514 Mutants of the factor VII-activating protease and detection methods using specific antibodies
10/28/2008US7442513 Method of screening for agents that modulate a homer signaling pathway
10/28/2008US7442398 Phytase produced from Citrobacter braakii
10/28/2008US7442376 Glycoprotein hormone compositions containing two β subunits
10/28/2008US7442373 Antibodies against protective antigen and methods of use for passive immunization and treatment of anthrax
10/28/2008US7442160 Evolving new molecular function
10/28/2008CA2236948C Modified proteins and methods of their production
10/28/2008CA2225924C Recombinant mistletoe lectin
10/23/2008WO2008128234A1 Reduced phosphotransferase system activity in bacteria
10/23/2008WO2008127900A1 Methods of genetically encoding unnatural amino acids in eukaryotic cells using orthogonal trna/synthetase pairs
10/23/2008WO2008127515A1 Compositions and method for enhancing immune responses in mammals
10/23/2008WO2008127271A2 Interleukin -13 binding proteins
10/23/2008WO2008126847A1 Prophylactic or therapeutic agent for cancer
10/23/2008WO2008126785A1 Method of producing useful substance
10/23/2008WO2008126784A1 Method for production of glutathione or ϝ-glutamylcysteine
10/23/2008WO2008126783A1 Method for producing dipeptide
10/23/2008WO2008126401A1 Apparatus for refolding protein
10/23/2008WO2008126400A1 Column packing and column for refolding protein
10/23/2008WO2008067089A3 Light-regulated transcription system for use in prokaryotic organisms
10/23/2008WO2008028117A3 Glp-2 mimetibodies, polypeptides, compositions, methods and uses
10/23/2008WO2007134274A3 Antibodies to urokinase- type plasminogen activator receptor(upar)bind cancer stem cells: use in diagnosis and therapy
10/23/2008WO2007130886A3 Nutritional supplement and use thereof
10/23/2008WO2007124486A3 Bmp4 inhibitors
10/23/2008WO2007095746A9 Cancerous disease modifying antibodies
10/23/2008WO2007059511A3 Compositions and methods for modulating hemostasis
10/23/2008WO2006099207A3 Lyase enzymes, nucleic acids encoding them and methods for making and using them
10/23/2008US20080263688 Hafnia Phytase
10/23/2008US20080262211 Hepatitis-c virus type 4, 5 and 6
10/23/2008US20080262206 Method of Isolating Proteon Nucleation Centers from Blood and Other Biological Materials
10/23/2008US20080262204 A purified affinity-matured antibody or a portion thereof having binding specificity for 83 kDa protective antigen (PA83) of Bacillus anthracis; confers protection to a host against a tripartite toxin of Bacillus anthracis; cloned from an anti-Bacillus anthracis PA83 hybridoma
10/23/2008US20080261903 Isolated polynucleotide encoding a Regulated in chronic obstructive pulmonary disease Kinase polypeptide; host cell; hybridization; screening; prediction, diagnosis; prognosis; chronic obstructive pulmonary disease, asthma, cancer, diseases of defective cell signaling
10/23/2008US20080261885 Conglycinin fragments extracted from ground, defatted soy, then precipitated by treatment with aqueous ethanol; metal affinity chromatography; treating with chymotrypsin; hyperlipidemia
10/23/2008US20080261863 Pegylation of Vasoactive Intestinal Peptide (Vip) / Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 2 (Vpac2) Agonists and Methods of Use
10/23/2008US20080261861 2-Micron Family Plasmid and Use Thereof
10/23/2008US20080261833 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
10/23/2008US20080261311 Translation systems with orthogonal aminoacyl tRNA synthetase; membrane proteins
10/23/2008US20080261274 Restoration of Cholesterol Independence and Its Use as a Selectable Marker in Ns0 Cell Culture
10/23/2008US20080261273 PROCESS FOR PRODUCING HMG-CoA REDUCTASE INHIBITORS
10/23/2008US20080261272 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA
10/23/2008US20080261271 Expression of hiv polypeptides and production of virus-like particles
10/23/2008US20080261270 Expression vector comprising nucleotide sequences estrogen receptor protein for use in inhibition of heregulin binding and treatment of breast and prostate cancers
10/23/2008US20080261269 Alleles of the oxyr gene from coryneform bacteria
10/23/2008US20080261268 5-Substituted Hydantoin Racemase, Dna Encoding the Same, Recombinant Dna, Transformed Cell, and Process for Production of Optically Active N-Carbamylamino Acid or Optically Active Amino Acid
10/23/2008US20080261267 Cellulases from Rumen
10/23/2008US20080261241 Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteins
10/23/2008US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor
10/23/2008US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
10/23/2008US20080260903 Phospholipase
10/23/2008US20080260812 Therapeutic Medicine Containing Monoclonal Antibody Against Folate Receptor Beta (Fr-Beta)
10/23/2008US20080260767 Novel Protein Which can be Used, in Particular, for the In Vitro Isolation and Prevention of Legionella Pneumophila Infections
10/23/2008US20080260761 Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins
10/23/2008US20080260759 Novel Mite Allergen
10/23/2008US20080260757 Bispecific Fusion Antibodies With Enhanced Serum Half-Life
10/23/2008US20080260755 Therapeutic fusion protein in which coagulation factor sequences are fused to half-life enhancing polypeptide for use in treatment of hemophilia
10/23/2008US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260746 Erythropoietin polypeptide for use in treatment and prevention of viral, skin, nervous system, autoimmune, cardiovascular, kidney, cell proliferative and cardiovascular disorders
10/23/2008US20080260743 Means and Methods for Detecting Methylated Dna
10/23/2008US20080260741 Preventive and/or Therapeutic Agent for Cancer
10/23/2008US20080260738 Single chain fc, methods of making and methods of treatment
10/23/2008US20080260735 Glycoprotein-340 for use in targeted destruction of cancer tissues; immunotherapy
10/23/2008US20080260733 Humanized collagen antibodies and related methods
10/23/2008US20080260729 Using RNA interference and/or endothelial growth factor specific immunoglobulins to target, treat and prevent cell proliferative disorsders
10/23/2008US20080260721 Nucleotide sequences coding regulatory-associated protein of mTOR (Raptor) protein for use in identifying modulators for prevention and treatment of cancer and diabetes
10/23/2008US20080260713 Neukinase, A Downstream protein of neuregulin
10/23/2008US20080260711 Detoxifizyme with Activity of Transforming Aflatoxin and the Gene Encodes Thereof
10/23/2008US20080260642 Fusion protein mixture containing bacteriophage specific protein and ligand; detection of target structures; peptide binding signal generating material
10/23/2008CA2688693A1 Interferons of rhesus and cynomolgus origin and uses thereof
10/23/2008CA2683960A1 Methods of genetically encoding unnatural amino acids in eukaryotic cells using orthogonal trna/synthetase pairs
10/23/2008CA2662701A1 Interleukin-13 binding proteins
10/23/2008CA2648864A1 Gene defects and mutant alk kinase in human solid tumors
10/22/2008EP1983059A2 Process for producing dipeptides
10/22/2008EP1983048A1 Novel protein expression system
10/22/2008EP1983001A2 Antibodies to mammalian Langerhans cell antigen and their uses
10/22/2008EP1982998A1 Nucleic acid binding proteins
10/22/2008EP1982990A1 Cytokine receptor common gamma chain like
10/22/2008EP1982732A2 Factor VII or VIIA-like molecules
10/22/2008EP1981992A2 Promoter engineering and genetic control
1 ... 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 ... 1125